XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated 
Deficit
Common stock, shares outstanding at beginning of period (in shares) at Dec. 31, 2023   72,533,754        
Stockholders' equity at beginning of period at Dec. 31, 2023 $ 45,893 $ 7 $ (5,445) $ 690,055 $ (24,910) $ (613,814)
Stockholders’ Deficit            
Shares issued in connection with employee stock plans (in shares)   109,691        
Stock-based compensation expense and vesting of restricted stock units 1,834     1,834    
Preferred stock accretion 0          
Other comprehensive loss (1,733)       (1,733)  
Net loss (16,447)         (16,447)
Common stock, shares outstanding at end of period (in shares) at Mar. 31, 2024   72,643,445        
Stockholders' equity at end of period at Mar. 31, 2024 $ 29,547 $ 7 (5,445) 691,889 (26,643) (630,261)
Mezzanine Equity at beginning of period (in shares) at Dec. 31, 2024 28,000.00001          
Mezzanine Equity at beginning of period at Dec. 31, 2024 $ 23,861          
Mezzanine Equity            
Conversion of convertible preferred stock (in shares) (7,000)          
Conversion of convertible preferred stock $ (7,000)          
Preferred stock accretion $ 1,513          
Mezzanine Equity at end of period (in shares) at Mar. 31, 2025 21,000.00001          
Mezzanine Equity at end of period at Mar. 31, 2025 $ 18,374          
Common stock, shares outstanding at beginning of period (in shares) at Dec. 31, 2024 89,861,035 89,861,035        
Stockholders' equity at beginning of period at Dec. 31, 2024 $ (7,731) $ 9 (5,445) 718,797 (27,455) (693,637)
Stockholders’ Deficit            
Shares issued in connection with employee stock plans (in shares)   288,846        
Stock-based compensation expense and vesting of restricted stock units 687     687    
Conversion of convertible preferred stock (in shares)   3,784,688        
Conversion of convertible preferred stock 7,000     7,000    
Preferred stock accretion (1,513)     (1,513)    
Other (40)         (40)
Other comprehensive loss (741)       (741)  
Net loss $ (9,041)         (9,041)
Common stock, shares outstanding at end of period (in shares) at Mar. 31, 2025 93,934,569 93,934,569        
Stockholders' equity at end of period at Mar. 31, 2025 $ (11,379) $ 9 $ (5,445) $ 724,971 $ (28,196) $ (702,718)